Finance

Lists
EIKN:NASDAQ
Eikon Therapeutics Inc
US$ ६.७२
-०.०७%
(-०.००५०) 1D
अक्टोबर १४, १३:०८:४२ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EIKN...
Open
US$ ६.६९
High
US$ ६.९०
Low
US$ ६.४५
Mkt. cap
३६.३७ करोड
Avg. vol.
६.२५ लाख
Volume
१.९४ लाख
P/E ratio
०.१३
52-wk high
US$ १७.४०
52-wk low
US$ ६.४५
EPS
US$ ५३.५७
No. of employees
३८४
Open
US$ ६.६९
High
US$ ६.९०
Low
US$ ६.४५
Mkt. cap
३६.३७ करोड
Avg. vol.
६.२५ लाख
Volume
१.९४ लाख
P/E ratio
०.१३
52-wk high
US$ १७.४०
52-wk low
US$ ६.४५
EPS
US$ ५३.५७
No. of employees
३८४
News stories
From web sources and news partners
About Eikon Therapeutics Inc
CEO-
Employees३८४
Founded२०१९
HeadquartersMillbrae, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to EIKN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for EIKN in the last 3 months.
Highest
Current US$ ६.७२
US$ ३२.०० (+३७६.५५%)
Average
US$ ३१.०० (+३६१.६५%)
Lowest
US$ २९.०० (+३३१.८७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Buy
Maintained
US$ ३२.००
+३७६.५%
09/28/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
US$ ३२.००
+३७६.५%
08/17/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
US$ २९.००
+३३१.९%
08/17/2026
Robert Driscoll
Wedbush
Sell
Maintained
US$ ५.००
-२५.५%
05/12/2026
Joseph Catanzaro
Mizuho Securities
Buy
Initiated
US$ २६.००
+२८७.२%
03/02/2026
Last report
२०२६ अगस्ट १३
Fiscal period
Q2 2026
-US$ १.६३ / -US$ १.४६
-११.५४%miss
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
६.६२ करोड
६.५२ करोड
७.०० करोड
७.५५ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९१ करोड
१.७७ करोड
१.७३ करोड
१.७९ करोड
Operating expense
८.५३ करोड
८.३० करोड
८.७३ करोड
९.३४ करोड
Total operating expenses
८.५३ करोड
८.३० करोड
८.७३ करोड
९.३४ करोड
Operating income
-८.५३ करोड
-८.३० करोड
-८.७३ करोड
-९.३४ करोड
Other non operating income
-२.०० हजार
-९.०० हजार
-१.०० हजार
-५२.०० हजार
EBT including unusual items
-१०.५२ करोड
-७.९७ करोड
-८.३० करोड
-८.८४ करोड
EBT excluding unusual items
-८.०९ करोड
-७.९४ करोड
-८.३० करोड
-८.८४ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१०.५२ करोड
-७.९७ करोड
-८.३० करोड
-८.८४ करोड
Net profit margin
-
-
-
-
Earnings per share
-
-२६.२३
-२.४६
-१.६३
Interest and investment income
४४.३४ लाख
३५.२२ लाख
४३.८० लाख
५०.३७ लाख
Interest expense
-
-
-
-
Net interest expenses
४४.३४ लाख
३५.२२ लाख
४३.८० लाख
५०.३७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८.११ करोड
-७.७६ करोड
-८.२१ करोड
-८.८३ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू